Enhanced Ultrasound-Guided Blood-Brain Barrier Opening

Publication ID: 24-11857812_0006_PTD
Published: October 28, 2025
Category:Direct Improvements & Enhancements

Legal Citation

pr1or.art Inc., “Enhanced Ultrasound-Guided Blood-Brain Barrier Opening,” Published Technical Disclosure No. 24-11857812_0006_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857812_0006_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,812.

Summary of the Inventive Concept

A novel system and method for improved ultrasound-guided blood-brain barrier opening, enhancing treatment outcomes and patient safety through optimized energy delivery, real-time monitoring, and personalized approaches.

Background and Problem Solved

The original patent, 'Ultrasound guided opening of blood-brain barrier', presents a promising solution for treating brain diseases. However, it has limitations in terms of energy delivery, monitoring, and adaptability. The new inventive concept addresses these limitations by introducing dynamically adjustable transducer elements, real-time monitoring capabilities, and personalized treatment approaches, thereby improving the safety and efficacy of blood-brain barrier opening.

Detailed Description of the Inventive Concept

The enhanced system comprises a transducer array with dynamically adjustable elements, allowing for optimized energy delivery and selective barrier opening in target regions. Real-time monitoring is achieved through ultrasound imaging, enabling the detection of changes in barrier permeability and adjustment of ultrasound energy delivery accordingly. Additionally, a cooling system prevents overheating of the transducer and surrounding tissue during prolonged treatment sessions. The system can be personalized using machine learning algorithms to predict optimal ultrasound energy delivery parameters based on individual patient characteristics and treatment outcomes. Furthermore, the system can be combined with targeted drug delivery, enhancing agent uptake through selective blood-brain barrier opening.

Novelty and Inventive Step

The new claims introduce novel features that distinguish the enhanced system from the original patent. The dynamically adjustable transducer elements, real-time monitoring capabilities, and personalized approaches provide a significant improvement over the existing technology. These advancements are non-obvious and represent a substantial inventive step, as they require a deep understanding of ultrasound technology, medical imaging, and machine learning.

Alternative Embodiments and Variations

Alternative embodiments of the enhanced system could include different transducer array configurations, varying cooling system designs, or alternative machine learning algorithms. Additionally, the system could be adapted for use in other medical applications, such as targeted cancer treatment or gene therapy.

Potential Commercial Applications and Market

The enhanced ultrasound-guided blood-brain barrier opening system has significant commercial potential in the medical device industry, particularly in the areas of neurology and oncology. The system's ability to improve treatment outcomes and patient safety makes it an attractive solution for hospitals, clinics, and research institutions. The market for this technology is substantial, with an estimated value of over $1 billion in the next five years.

Field of Art

Medical ultrasound technology with specific focus on neurological interventional procedures, requiring expertise in biomedical engineering, medical imaging, ultrasound physics, and interventional medical device design

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer or medical device researcher with advanced degree, 5-10 years experience in ultrasound technology, familiar with blood-brain barrier treatment techniques, advanced imaging methods, and medical device optimization strategies

Obviousness Rationale

A person skilled in the art would recognize that the PTD's variations represent predictable engineering improvements to the source patent's ultrasound blood-brain barrier treatment system. The disclosed enhancements like dynamic transducer element adjustment, real-time monitoring, and machine learning optimization are logical extensions of existing ultrasound guidance techniques. These modifications represent incremental technological developments that would be obvious to implement given the foundational teachings of the source patent.

Obvious Combinations & Variations

Source Patent Element
Treatment ultrasound transducer with multiple elements for brain targeting
PTD Variation
Dynamically adjustable transducer array with selective element activation
Obviousness Reasoning
Predictable design optimization using known phased array techniques to improve energy delivery precision
Source Patent Element
Position tracking and image guidance system
PTD Variation
Real-time monitoring of blood-brain barrier permeability changes
Obviousness Reasoning
Logical extension of existing imaging guidance to provide more granular treatment feedback using standard medical imaging techniques
Source Patent Element
Robotic manipulator for transducer positioning
PTD Variation
Machine learning algorithms for predicting optimal ultrasound parameters
Obviousness Reasoning
Applying computational optimization techniques to medical device control is a known approach for improving treatment precision
Source Patent Element
Ultrasound energy delivery for blood-brain barrier disruption
PTD Variation
Integrated cooling system to prevent tissue overheating
Obviousness Reasoning
Thermal management is a standard engineering consideration for energy-delivering medical devices, representing a predictable safety enhancement
Source Patent Element
Blood-brain barrier opening technique
PTD Variation
Combined targeted drug delivery with selective barrier opening
Obviousness Reasoning
Logical therapeutic extension combining known ultrasound permeabilization with pharmaceutical intervention strategies
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857812, a person having ordinary skill in the art would find the technical variations disclosed herein to be obvious modifications of the prior art. The incremental improvements in ultrasound transducer design, real-time monitoring, and personalized treatment optimization represent predictable engineering developments that do not rise to the level of non-obvious invention, thereby rendering potential claims in this domain anticipated and obvious under 35 U.S.C. ยง 103.

Original Patent Information

Patent NumberUS 11,857,812
TitleUltrasound guided opening of blood-brain barrier
Assignee(s)Cordance Medical Inc.